Plasma Physics

Contains reports on two research projects.United States Atomic Energy Commission (Contract AT(30-1)-1842)United States Air Force, Electronic Systems Division (Contract AF19(604)-5992)National Science Foundation (Grant G-24073

Plasma Physics

Contains research objectives and reports on four research projects.U.S. Atomic Energy Commission (Contract AT(30- 1)- 1842)U.S. Air Force (Electronic Systems Division) under Contract AF 19(604)- 599

Microwave Gaseous Discharges

Contains research objectives and reports on three research projects.Atomic Energy Commission under Contract AT(30-1)184

Electrical and Magnetic Performance of the LHC Short Straight Sections

The Short Straight Section (SSS) for the Large Hadron Collider arcs, containing in a common cryostat the lattice quadrupoles and correction magnets, have now entered series production. The foremost features of the lattice quadrupole magnets are a two-in-one structure containing two 56 mm aperture, two-layers coils wound from 15.1 mm wide NbTi cables, enclosed by the stainless steel collars and ferromagnetic yoke, and inserted into the inertia tube. Systematic cryogenic tests are performed at CERN in order to qualify these magnets with respect to their cryogenic and electrical integrity, the quench performance and the field quality in all operating conditions. This paper reports the main results obtained during tests and measurements in superfluid helium. The electrical characteristics, the insulation measurements and the quench performance are compared to the specifications and expected performances for these magnets. The field in the main quadrupole is measured using three independent systems: 10-m long twin rotating coils, an automatic scanner, and single stretched wire. A particular emphasis is given to the integrated transfer function which has a spread of around 12 units rms in the production and is a critical issue. The do-decapole harmonic component, which required trimming through a change in coil shims, is also discussed. Finally, the magnetic axis measurements at room temperature and at 1.9 K, providing the nominal vertical shift for installation are reported

Plasma Physics

Contains reports on seven research projects.Atomic Energy Commission under Contract AT(30-1)1842Air Force Cambridge Research Center under Contract AF-19(604)-5992National Science Foundation (Grant G-9330

Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

BACKGROUND: Few new compounds are available for relapsed osteosarcoma. We retrospectively evaluated the activity of gemcitabine (G) plus docetaxel (D) in patients with relapsed high-grade osteosarcoma and high-grade spindle cell sarcoma of bone (HGS). METHODS: Patients receiving G 900 mg/m(2) d 1, 8; D 75 mg/m(2) d 8, every 21 days were eligible. Primary end-point: progression-free survival (PFS) at 4 months; secondary end-point: overall survival (OS) and response rate. RESULTS: Fifty-one patients were included, with a median age of 17 years (8–71), 26 (51 %) were pediatric patients. GD line of treatment: 2nd in 14 patients, ≥3rd in 37. 25 (49 %) patients had metastases limited to lungs, 26 (51 %) multiple sites. Histology: 40 (78 %) osteosarcoma, 11 (22 %) HGS. Eight (16 %) patients achieved surgical complete response (sCR2) after GD. Four-month PFS rate was 46 %, and significantly better for patients with ECOG 0 (ECOG 0: 54 % vs ECOG 1: 43 % vs ECOG 2: 0 %; p = 0.003), for patients undergoing metastasectomy after GD (sCR2 75 % vs no-sCR2 40 %, p = 0.02) and for osteosarcoma (osteosarcoma 56 % vs HGS 18 %; p = 0.05), with no differences according to age, line of treatment, and pattern of metastases. Forty-six cases had RECIST measurable disease: 6 (13 %) patients had a partial response (PR), 20 (43 %) had stable disease (SD) and 20 (43 %) had progressive disease (PD). The 1-year OS was 30 %: 67 % for PR, 54 % for SD and 20 % for PD (p = 0.005). CONCLUSIONS: GD is an active treatment for relapsed high-grade osteosarcoma, especially for ECOG 0 patients, and should be included in the therapeutic armamentarium of metastatic osteosarcoma

Microwave Gaseous Disharges

Contains reports on seven research projects.Atomic Energy Commission under Contract AT(30-1)184

Plasma Physics

Contains research objectives and reports on three research projects.U. S. Atomic Energy Commission under Contract AT(30-1)-1842National Science Foundation (Grant G-9330)U.S. Air Force (Electronic Systems Division) under Contract AF19(604)-599

Plasma Dynamics

Contains reports on three research projects.National Science Foundation under Grant G-9330Air Force Cambridge Research Center under Contract AF-19(604)-5992United States Air Force (WADD Contract AF33(616)-3984)Contract AF19(604)-4551 with Air Force Cambridge Research CenterAeronautical Accessories Laboratory, Wright Air Development Division, Wright-Patterson Air Force Base, Ohio (Air Force Contract AF33(616)-3984, Project 8149, Task No. 61098)Atomic Energy Commission under Contract AT(30-1)-184